Adenoviral vector expressing hepatocyte growth factor promotes liver regeneration by preoperative injection: The advantages of performing selective injection to the remnant lobe

Surgery

Volumn 141, Issue 4, 2007, Pages 511-519

  Ueno, Masaki ^a   Uchiyama, Kazuhisa ^a   Nakamori, Mikihito ^a   Ueda, Kentaro ^a   Iwahashi, Makoto ^a   Ozawa, Satoru ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BROXURIDINE; DIMETHYLNITROSAMINE; PHOSPHATE BUFFERED SALINE; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; LABELING INDEX; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER REGENERATION; LIVER WEIGHT; MALE; MORPHOLOGY; NONHUMAN; PARTIAL HEPATECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENETIC VECTORS; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; INJECTIONS, INTRALESIONAL; LIVER REGENERATION; MALE; PREMEDICATION; RATS; RATS, SPRAGUE-DAWLEY; TRANSDUCTION, GENETIC;

EID: 33947314972     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.10.006     Document Type: Article

References (34)

1. Liver Cancer Study Group of Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211 (1990) 277-287
2. Kokudo N., Kothary P.C., Eckhauser F.E., and Raper S.E. Transforming growth factor-alpha (TGF-alpha) improves hepatic DNA synthesis after hepatectomy in cirrhotic rats. J Surg Res 52 (1992) 648-655
3. Imamura H., Sano K., Sugawara Y., Kokudo N., and Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12 (2005) 16-22
4. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342 (1989) 440-443
5. Boros P., and Miller C.M. Hepatocyte growth factor: a multifunctional cytokine. Lancet 345 (1995) 293-295
6. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
7. Weidner K.M., Arakaki N., Hartmann G., Vandekerckhove J., Weingart S., Rieder H., et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci U S A 88 (1991) 7001-7005
8. Shiota G., Wang T.C., Nakamura T., and Schmidt E.V. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 19 (1994) 962-972
9. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373 (1995) 699-702
10. Phaneuf D., Chen S.J., and Wilson J.M. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol Med 6 (2000) 96-103
11. Yasuda H., Imai E., Shiota A., Fujise N., Morinaga T., and Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24 (1996) 636-642
12. Matsuda Y., Matsumoto K., Yamada A., Ichida T., Asakura H., Komoriya Y., et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26 (1997) 81-89
13. Kaido T., Seto S., Yamaoka S., Yoshikawa A., and Imamura M. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res 74 (1998) 173-178
14. Ueki T., Kaneda Y., Tsutsui H., Kuwabara Y., Shinno E., Nonome K., et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5 (1999) 226-230
15. Xue F., Takahara T., Yata Y., Kuwabara Y., Shinno E., Nonome K., et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 52 (2003) 694-700
16. Shiota G., Kuhisada T., Oyama K., Udagawa A., Nomi T., Tanaka K., et al. In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acethylaminofluorene/partial hepatectomy model in rats. FEBS Lett 470 (2000) 325-330
17. Brody S.L., and Crystal R.G. Adenovirus-mediated on vivo gene transfer. Ann NY Acad Sci 716 (1994) 90-101
18. Ozawa S., Uchiyama K., Nakamori M., Ueda K., Iwahashi M., Ueno H., et al. Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy. Surgery 139 (2006) 563-573
19. Jezequel A.M., Mancini R., Rinaldesi M.L., Ballardini G., Fallani M., Bianchi F., et al. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 8 (1989) 42-52
20. Pritchard D.J., and Butler W.H. Apoptosis-the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J Pathol 158 (1989) 253-260
21. Higgins G.M., and Anderson R.M. Experimental pathology of the liver: restoration of liver of the white rat following partial surgical removal. Arch Pathol 12 (1931) 186-202
22. Kawaida K., Matsumoto K., Shimizu H., and Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci U S A 91 (1994) 4357-4361
23. 3. Cancer Res 22 (1962) 842-849
24. Tanaka Y., Mak K.M., and Lieber C.S. Immunohistochemical detection of proliferating lipocytes in regenerationg liver. J Pathol 160 (1990) 129-134
25. Widmann J., and Fahimi H.D. Proliferation of molecular phagocytes (Kupffer cells) and endothelial cells in regenerating rat liver. Am J Pathol 80 (1975) 349-366
26. Garcia B.J., Siller L.F., Miranda A., Aguilar L.K., Aguilar C.E., and Armendariz B.J. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion. Gene Therapy 9 (2002) 127-134
27. Xuehai Y.E., Marina J., and Patricio E.R. Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney. Human Gene Therapy 11 (2000) 621-627
28. Scholl B., Gervaz P., Martinet O., Ksontini R., Krueger T., Sahli R., et al. Adenovirus-mediated gene transfer into selected liver segments using a vascular exclusion techinique. Eur Surg Res 33 (2001) 348-354
29. Inagaki Y., Kushida M., Higashi K., Itoh J., Higashiyama R., Hong Y.Y., et al. Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 129 (2005) 259-268
30. Ueda K., Iwahashi M., Nakamori M., Nakamura M., Matsuura I., Ojima T., et al. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer. Surgery 133 (2003) 309-317
31. Liu Y., Rajur K., Tolbert E., and Dworkin L.D. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 58 (2000) 2028-2043
32. Tajima H., Matsumoto K., and Nakamura T. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett 291 (1991) 229-232
33. Shiota G., Rhoads D.B., Wang T.C., Nakamura T., and Schmidt E.V. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A 89 (1992) 373-377
34. Sakata H., Takayama H., Sharp R., Rubin J.S., Merlino G., and LaRochelle W.J. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 7 (1996) 1513-1523